News, Research & Insights
News, Insights and Research Publications
Find the latest insights from across our organisation

Correlations between receptor occupancy change and mental state in patients using long-acting injectable antipsychotics: MIDILIA pilot study

Fatalities following DMT use: two case reports and a review of the literature.

Identification of 5-aminometonitazene and 5-acetamidometonitazene in a postmortem case: are nitro-nitazenes unstable?

Plasma clozapine, norclozapine, and the clozapine: norclozapine ratio in relation to prescribed dose and other factors: data from a therapeutic drug monitoring service, 1993–2007

Measurement of the Direct Oral Anticoagulants Apixaban, Dabigatran, Edoxaban, and Rivaroxaban in Human Plasma Using Turbulent Flow Liquid Chromatography With High-Resolution Mass Spectrometry

A 13-steroid serum panel based on LC-MS/MS: use in detection of adrenocortical carcinoma
News & Insights
Analytical Expert Labs completes acquisition of AttoSure and AttoLife
Analytical Expert Labs has completed the acquisition of AttoSure and AttoLife, together with specified activities and assets of AttoDNA, further strengthening the Group’s scientific and analytical capabilities.
Analytical Expert Labs acquires TICTAC Communications Ltd, strengthening drug identification and intelligence capabilities
Tuesday 5th May 2026: Analytical Expert Labs, a leading provider of forensic, analytical and bioanalytical services, is pleased to announce the acquisition of TICTAC Communications Ltd, a specialist provider of drug identification tools, intelligence and analytical...
Forensic Access Group Rebrands as Analytical Expert Labs
17 October 2025: Forensic Access Group, the UK’s leading specialist provider of forensic, scientific and analytical services, is proud to announce it is today rebranding as Analytical Expert Labs Ltd. Analytical Expert Labs brings together specialist laboratories...
Launch of Certis BioLabs Limited Brings Court-Approved Drug, Alcohol and DNA Testing to the Public
13th October 2025: Certis BioLabs Limited is delighted to announce its launch, offering drug, alcohol and DNA testing. Affordable testing will be available to members of the public, employers, healthcare providers and those who require analysis as part of a private or...